Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patientsSibutramine and blood pressure

被引：0
|
作者：
Andreas L. Birkenfeld
Christoph Schroeder
Tobias Pischon
Jens Tank
Friedrich C. Luft
Arya M. Sharma
Jens Jordan
机构：
[1] Franz-Volhard Clinical Research Center,Dept. of Nutrition
[2] Medical Faculty of the Charité and Helios Klinikum,Canada Research Chair for Cardiovascular Obesity Research & Management, Dept. of Medicine
[3] Franz Volhard Clinical Research Center Haus 129,undefined
[4] Charité Campus Buch,undefined
[5] Harvard School of Public Health,undefined
[6] Channing Laboratory,undefined
[7] McMaster University,undefined
[8] Hamilton General Hospital,undefined
来源：
Clinical Autonomic Research | 2005年 / 15卷
关键词：
norepinephrine transporter; sympathetic nervous system; obesity; hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：200 / 206
页数：6
相关论文
共 50 条
  • [1] Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients - Sibutramine and blood pressure
    Birkenfeld, AL
    Schroeder, C
    Pischon, T
    Tank, J
    Luft, FC
    Sharma, AM
    Jordan, J
    CLINICAL AUTONOMIC RESEARCH, 2005, 15 (03) : 200 - 206
  • [2] Paradoxical effect of sibutramine on autonomic cardiovascular regulation
    Birkenfeld, AL
    Schroeder, C
    Boschmann, M
    Tank, J
    Franke, G
    Luft, FC
    Biaggioni, I
    Sharma, AM
    Jordan, J
    CIRCULATION, 2002, 106 (19) : 2459 - 2465
  • [3] Paradoxical effect of sibutramine on autonomic cardio-vascular regulation in obese hypertensive patients
    Jordan, J
    Birkenfeld, AL
    Schroeder, C
    Pischon, T
    Tank, J
    Luft, FC
    Sharma, AM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R142 - R142
  • [4] The effect of sibutramine on body weight and blood pressure in obese women
    Petrogianopoulos, C
    Papamichael, K
    Kalogeropoulos, S
    Kostakos, N
    Svoukas, G
    Zaharof, A
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S157 - S157
  • [5] Six-week treatment with sibutramine in hypertensive obese/overweight patients with high cardiovascular risk reduces blood pressure-an analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Torp-Pedersen, C.
    Caterson, I.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A.
    Sharma, A. M.
    James, W. P. T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 870 - 870
  • [6] Autonomic control of blood pressure and heart rate in obese hypertensive dogs
    Truett, AA
    Borne, AT
    Poincot, MA
    West, DB
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 270 (03) : R541 - R549
  • [7] Sibutramine reduces body weight and does not alter blood pressure control in obese hypertensive patients
    Faria, AN
    Ribeiro, FF
    Lerario, DD
    Kohlmann, N
    Ferreira, SRG
    Ribeiro, AB
    Zanella, MT
    JOURNAL OF HYPERTENSION, 2002, 20 : S208 - S208
  • [8] Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients
    Faria, AN
    Ribeiro Filho, FF
    Kohlmann, NE
    Gouvea Ferreira, SR
    Zanella, MT
    DIABETES OBESITY & METABOLISM, 2005, 7 (03): : 246 - 253
  • [9] The role of Rimonabant in blood pressure regulation of obese hypertensive patients
    Karakousis, K.
    Karapoulios, D.
    Rizakis, N.
    Oikonomou, K.
    Vassileios, P.
    JOURNAL OF HYPERTENSION, 2008, 26 : S221 - S221
  • [10] Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
    James, W. Philip T.
    Caterson, Ian D.
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc F.
    Maggioni, Aldo P.
    Torp-Pedersen, Christian
    Sharma, Arya M.
    Shepherd, Gillian M.
    Rode, Richard A.
    Renz, Cheryl L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10): : 905 - 917
12345